|
An overview of the influence of the different adenosine receptor agonists/antagonists used on the latency of the ascending contraction. The influence on latency is given for the highest concentration applied |
|||
| Drug |
Experiments (n) |
Mean ± SEM |
Significance |
|
|
|||
| DPCPX 10-6M |
10 |
134 ± 14% |
P < 0.05 |
| CPA 10-8M |
16 |
171 ± 22% |
P < 0.05 |
| ZM 241385 10-6M |
16 |
106 ± 6% |
n.s. |
| CGS 21680 3 × 10-7M |
11 |
104 ± 9% |
n.s. |
| Alloxazine 3 × 10-7M |
9 |
104 ± 7% |
n.s. |
| MRS 1191 10-7M |
11 |
113 ± 15% |
n.s. |
| IB-MECA 3 × 10-7M |
8 |
111 ± 14% |
n.s. |
Storr et al. BMC Neuroscience 2002 3:21 doi:10.1186/1471-2202-3-21 |
|||